ChristopherMarkPerkinsMD
Internal Medicine • Bainbridge Island, WASenior Medical Director, Pharmaceutical Product Development, Inc
Dr. Perkins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Sunrise Dr NE
Bainbridge Island, WA 98110Phone+1 919-215-3765
Education & Training
University of North Carolina HospitalsResidency, Internal Medicine, 1985 - 1988
Duke University School of MedicineClass of 1985
Certifications & Licensure
NC State Medical License 1988 - 2021
Publications & Presentations
PubMed
- 15 citationsAlbiglutide for the treatment of type 2 diabetes mellitus: An integrated safety analysis of the HARMONY phase 3 trialsBo Ahrén, Molly C. Carr, Karen Murphy, Christopher Perkins, Marc Rendell
Diabetes Research and Clinical Practice. 2017-04-01 - 84 citationsEfficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in pati...Michael A. Nauck, Murray Stewart, Christopher Perkins, Angela Jones-Leone, Fred Yang
Diabetologia. 2016-02-01 - 99 citationsGrowth-modulating plasma tripeptide may function by facilitating copper uptake into cells.Loren Pickart, Jonathan H. Freedman, W. John Loker, Jack Peisach, Christopher M. Perkins
Nature. 1980-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
